Gastrointestinal stromal sarcomas, formerly categorized as leiomyosarcomas
of gastrointestinal origin, have a common pattern of intraperitoneal dissem
ination. Despite surgical resection with or without adjuvant systemic chemo
therapy the vast majority of these patients succumb to intraperitoneal sarc
omatosis and/or hepatic metastases. In an attempt to improve upon the morbi
dity and mortality associated with this disease we and several other center
s have begun treating these patients with intraperitoneal chemotherapy. We
have found that aggressive surgical resection with postoperative intraperit
oneal chemotherapy has significantly lowered the peritoneal recurrence rate
in patients with recurrent gastrointestinal stromal sarcomas as compared t
o those who have undergone surgical resection alone. However, this treatmen
t approach has proven to be ineffective in preventing hepatic metastases, a
nd thus has had little effect upon overall survival. With the treatment of
primary rather than recurrent disease we hope to interrupt the disease proc
ess at an earlier stage further decreasing peritoneal recurrences and poten
tially improving survival. (C) 2000 Elsevier Science Ltd. All rights reserv
ed.